Andelyn Scales AAV Manufacturing for Diabetes Gene Therapy
Columbus, Ohio, September 1, 2026 Andelyn Biosciences has announced that Genprex, Inc. has selected the contract development and manufacturing...
Keenova Therapeutics
Advertisement
Keenova Launches Mixed Reality Tool for Hand Health
Dublin, Ireland, September 1, 2026 Keenova Therapeutics plc has announced new initiatives for the second annual National Hand Health...
Aethlon Medical Reports Encouraging Hemopurifier Trial Results
SAN DIEGO, California, July 13, 2026 Aethlon Medical, Inc. has announced encouraging interim findings from the second patient cohort...
Keenova Publishes New Real-World Acthar Gel Autoimmune Data
DUBLIN, Ireland, July 13, 2026 Keenova Therapeutics plc has announced the publication of a new peer-reviewed real-world evidence study...
BioLineRx and Hemispherian Report Promising GLIX1 Ovarian Cancer Data
TEL AVIV, Israel & OSLO, Norway, July 8, 2026 BioLineRx Ltd. and Hemispherian AS have announced encouraging new preclinical...
Advertisements
Keenova Reports Positive Phase 3 Results for XIAFLEX
DUBLIN, Ireland, July 8, 2026 Keenova Therapeutics plc has announced positive Phase 3 clinical trial results for XIAFLEX® (collagenase...
Keenova Highlights Updated XIAFLEX Data for Peyronie’s Disease at AUA 2026
DUBLIN, May 15, 2026 Keenova Therapeutics announced updated clinical findings on XIAFLEX® (collagenase clostridium histolyticum) for the treatment of...
Advertisement
